Skip to main content
OpenTrials
Completed

NCT Number: NCT02509897

Normobaric Hypoxic Training and Multiple Sclerosis

To study the effects of normobaric hypoxic training on cardiorespiratory fitness, resting, postprandial and exercise activity energy expenditure, immunoregulatory functions and serum erythropoietin levels in relapsing-remitting multiple sclerosis patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Experimental & Clinical Research Center

Berlin, 13125, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • stable immunomodulatory therapy
  • expanded disability status scale score < 4.5
  • body mass index 18.5 - 29.9 kg/m2

Exclusion criteria

  • clinically relevant heart, lung, liver, and kidney diseases

Treatment and study plan

Hypoxic training

Other

Hypoxic training 3 times per week four four weeks

Normoxic training

Other

Normoxic training 3 times per week four four weeks

Primary outcomes

  1. Activity energy expenditure measured by indirect calorimetry (respiratory chamber)

    Time frame: Change from baseline at 4 weeks

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Official study title

Cardiorespiratory, Metabolic and Immunoregulatory Response to Hypoxia in Multiple Sclerosis Patients: A Pilot Study

Acronym: MS_EPOXI

Important dates

Study start
2015
Primary completion
2017
Study completion
2018
First posted
Jul 28, 2015
Registry last updated
Jul 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.